Director/PDMR Shareholding
Centrica plc (the 'Company')
21 September 2026
Notification of Transactions of Directors
The Company was notified that three Directors acquired Centrica plc ordinary shares of 6 14/81 pence ('Shares').
The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Kevin O'Byrne
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification/Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Centrica plc
b)
LEI
E26EDV109X6EEPBKVH76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 6 14/81 pence (Shares)
GB00B033F229
b)
Nature of the transaction
Purchase of 68,000 Shares in the Company
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£1.4793
£1.4792
67,400
600
d)
Aggregated information
Volume
Price
Total
68,000
£1.479
£100,592.34
e)
Date of the transaction
21 September 2026
f)
Place of the transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Christopher O'Shea
2
Reason for the notification
a)
Position/status
Executive Director
b)
Initial notification/Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Centrica plc
b)
LEI
E26EDV109X6EEPBKVH76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Ordinary shares of 6 14/81 pence
GB00B033F229
b)
Nature of the transaction
Purchase of 68,055 Shares in the Company
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£1.485413
£1.483268
£1.480787
£1.482141
3,575
30,750
20,252
13,478
d)
Aggregated information
Volume
Price
Total
68,055
£1.482
£100,886.04
e)
Date of the transaction
21 September 2026
f)
Place of the transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Russell O'Brien
2
Reason for the notification
a)
Position/status
Executive Director
b)
Initial notification/Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Centrica plc
b)
LEI
E26EDV109X6EEPBKVH76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Ordinary shares of 6 14/81 pence
GB00B033F229
b)
Nature of the transaction
Purchase of 67,394 Shares in the Company
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£1.483800
67,394
d)
Aggregated information
Total
£99,999.22
e)
Date of the transaction
21 September 2026
f)
Place of the transaction
London Stock Exchange (XLON)
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHPPUBABUPQGCG
